Big Gain For Baudax Bio, Inc.
Fri, Jun 30, 2023 at 07:58 PM
Baudax Bio, Inc. (BXRX:NASDAQ) rocketted at $1.17, representing a gain of 124.9%. On Fri, Jun 30, 2023, BXRX:NASDAQ hit a New 2-Week High of $1.17. The stock appeared on our News Catalysts scanner on Fri, Jun 30, 2023 at 08:22 AM in the 'ACQUISITION' category. From Fri, Jun 16, 2023, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Tue, Apr 25, 2023 at $3.47 with a volume of 34M+.
About Baudax Bio, Inc. (BXRX:NASDAQ)
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings.
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 2900%
- Baudax Bio, Inc. (BXRX:NASDAQ), 124.91%
- VBI Vaccines Inc. (VBIV:NASDAQ), 75%
- Renalytix AI plc (RNLX:NASDAQ), 43.84%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 39.67%
- Rackspace Technology Inc. (RXT:NASDAQ), 38.78%
- Cyteir Therapeutics Inc. (CYT:NASDAQ), 35.42%
- Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ), 27.98%
- PainReform Ltd. (PRFX:NASDAQ), 27.06%
- Gracell Biotechnologies Inc. (GRCL:NASDAQ), 27%